Skip to main content

Freenome, Inc.

FRNM
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0002017526

No open-market purchases or sales by Freenome, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $95.7M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −7 vs. previous quarter
27
13F valueReported value at the end of Q2 2026
$95.7M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding FRNM, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding FRNM at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Freenome, Inc. insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Freenome, Inc. insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Freenome, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 27 holders
Institutions holding FRNM in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Farallon Capital Management, L.L.C.2,250,000$24.5M0.14%00.0%Unchanged
One Fin Capital Management LP843,482$9.18M3.21%00.0%Unchanged
Ra Capital Management, L.P.750,000$8.16M0.07%00.0%Unchanged
RTW Investments, LP742,500$8.08M0.07%00.0%Unchanged
ADAR1 Capital Management, LLC674,695$7.34M0.35%+175,114+35.1%Added
Highbridge Capital Management LLC661,493$7.22M0.25%+661,493New
Holocene Advisors, LP604,050$6.57M0.02%−21,123−3.4%Reduced
Standard Life Aberdeen plc578,565$6.29M0.01%00.0%Unchanged
Sculptor Capital LP424,700$4.62M0.05%00.0%Unchanged
Shay Capital LLC213,912$2.33M0.26%+62,928+41.7%Added